Hwang Woo-suk

Hwang Woo-suk is a South Korean Veterinarian and Researcher who gained international recognition for his work on Stem cell research and Cloning. He was a professor at Seoul National University and served as the director of the World Stem Cell Hub. His research focused on Somatic cell nuclear transfer and Therapeutic cloning, collaborating with scientists from Harvard University and the University of Pittsburgh. He also worked with Michael D. West from Advanced Cell Technology and Ian Wilmut from the Roslin Institute.

● Early Life and Education

Hwang Woo-suk was born in Buyeo County, South Chungcheong Province, South Korea, and grew up in a rural area. He attended Seoul National University for his undergraduate studies, where he earned a degree in Veterinary medicine from the College of Veterinary Medicine. He then pursued his graduate studies at the same university, earning a Master's degree and a Ph.D. in Veterinary medicine from the Graduate School of Seoul National University. During his studies, he was influenced by the work of James D. Watson and Francis Crick on the Structure of DNA, and he became interested in the field of Molecular biology and Genetics, particularly the work of David Baltimore and Rudolf Jaenisch.

● Career

Hwang Woo-suk began his career as a professor at Seoul National University, where he established a research laboratory focused on Stem cell research and Cloning. He collaborated with scientists from Stanford University, University of California, San Francisco, and the National Institutes of Health on various research projects, including the development of Embryonic stem cells and Induced pluripotent stem cells. He also worked with Shinya Yamanaka from Kyoto University and John Gurdon from the University of Cambridge on the development of Somatic cell nuclear transfer techniques. His research was published in prestigious scientific journals, including Nature, Science, and Cell, and he received funding from organizations such as the National Science Foundation and the Bill and Melinda Gates Foundation.

● Cloning Controversy

In 2004, Hwang Woo-suk announced that he had successfully cloned a Human embryo using Somatic cell nuclear transfer, a technique developed by Ian Wilmut and Keith Campbell from the Roslin Institute. The announcement was met with international attention and acclaim, and he was hailed as a pioneer in the field of Stem cell research. However, in 2005, an investigation by Seoul National University revealed that his research was fabricated, and he was accused of Scientific misconduct. The controversy involved scientists from Harvard University, University of Pittsburgh, and the National Institutes of Health, and it led to a re-evaluation of the ethics of Stem cell research and Cloning, with input from Leon Kass from the President's Council on Bioethics and Francis Collins from the National Human Genome Research Institute.

● Legacy and Impact

Despite the controversy surrounding his research, Hwang Woo-suk's work had a significant impact on the field of Stem cell research and Cloning. His research sparked a global debate on the ethics of Stem cell research and Cloning, with contributions from George W. Bush, Tony Blair, and the European Union. The controversy also led to a re-evaluation of the peer-review process and the importance of Scientific integrity, with discussions involving The Lancet, Journal of the American Medical Association, and the National Academy of Sciences. His work also inspired a new generation of scientists, including Shoukhrat Mitalipov from Oregon Health & Science University and Dieter Egli from Columbia University, to pursue research in the field of Stem cell biology and Regenerative medicine, with support from organizations such as the Howard Hughes Medical Institute and the Wellcome Trust.

● Later Life and Activities

After the controversy, Hwang Woo-suk continued to work on Stem cell research and Cloning, albeit at a reduced level. He established a private research institute, the Sooyoung Cell Therapy Center, where he focused on developing Stem cell therapies for Diseases such as Parkinson's disease and Diabetes mellitus. He also collaborated with scientists from China, Japan, and United States on various research projects, including the development of Induced pluripotent stem cells and Gene editing techniques, such as CRISPR and TALEN. His work has been recognized by organizations such as the Korean Academy of Science and Technology and the Asian-Pacific Association for Stem Cell Biology, and he has received awards from the Korean Government and the Seoul Metropolitan Government.